
zzso of cancer cells while minimizing damage to healthy cells is a primary goal of cancer zzso zzso selective drugs are urgently zzso Here we demonstrate a new zzso strategy for selective cancer therapy that zzso increased zzso zzso zzso and zzso zzso activities produced in zzso cancer zzso By zzso an zzso zzso group to zzso a masked zzso agent is created, which is serially activated by zzso and an zzso zzso zzso L zzso that remove the zzso group first and then the zzso zzso group liberating zzso The agent selectively kills human cancer cell lines with high zzso and zzso zzso In zzso studies confirm zzso growth zzso in zzso mice bearing human cancer zzso This zzso zzso of the masking group is a promising strategy for the next generation of zzso drug development that could be applied to many other zzso zzso 

